These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1510 related articles for article (PubMed ID: 17048972)
1. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Johannessen SI; Tomson T Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of new antiepileptic drugs. Gram L Epilepsia; 1996; 37 Suppl 6():S12-6. PubMed ID: 8941037 [TBL] [Abstract][Full Text] [Related]
3. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? Perucca E; Johannessen SI Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs. Perucca E Epilepsia; 1996; 37 Suppl 2():S8-S13. PubMed ID: 8641245 [TBL] [Abstract][Full Text] [Related]
5. Newer antiepileptic drugs. Towards an improved risk-benefit ratio. Patsalos PN; Sander JW Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080 [TBL] [Abstract][Full Text] [Related]
6. New antiepileptic drugs in pediatric epilepsy. Hwang H; Kim KJ Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657 [TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of the newer antiepileptic drugs. Bialer M Clin Pharmacokinet; 1993 Jun; 24(6):441-52. PubMed ID: 8513648 [TBL] [Abstract][Full Text] [Related]
8. The clinical pharmacokinetics of the new antiepileptic drugs. Perucca E Epilepsia; 1999; 40 Suppl 9():S7-13. PubMed ID: 10612356 [TBL] [Abstract][Full Text] [Related]
9. [Newer antiepileptic drugs]. Matsuura M No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Johannessen SI Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953 [TBL] [Abstract][Full Text] [Related]
13. New antiepileptic drug therapies. Bergin AM; Connolly M Neurol Clin; 2002 Nov; 20(4):1163-82. PubMed ID: 12616686 [TBL] [Abstract][Full Text] [Related]
14. [Antiepileptic drugs in North America]. Akiyama T; Otsubo H Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099 [TBL] [Abstract][Full Text] [Related]
15. Overview of the safety of newer antiepileptic drugs. Shorvon S; Stefan H Epilepsia; 1997; 38 Suppl 1():S45-51. PubMed ID: 9092960 [TBL] [Abstract][Full Text] [Related]
17. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. White HS Epilepsia; 1999; 40 Suppl 5():S2-10. PubMed ID: 10530688 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine. Elwes RD; Binnie CD Clin Pharmacokinet; 1996 Jun; 30(6):403-15. PubMed ID: 8792055 [TBL] [Abstract][Full Text] [Related]
19. Antiepileptic drugs in development: prospects for the near future. Leppik IE Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517 [TBL] [Abstract][Full Text] [Related]
20. Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain. Guay DR Am J Geriatr Pharmacother; 2003 Sep; 1(1):18-37. PubMed ID: 15555463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]